Advances in Multiple Sclerosis Research-Series I (Record no. 3023625)

MARC details
000 -LEADER
fixed length control field 05457naaaa2201657uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/68583
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220714200047.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number books978-3-03943-948-5
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783039439478
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783039439485
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/books978-3-03943-948-5
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
072 #7 - SUBJECT CATEGORY CODE
Subject category code M
Source bicssc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Matsoukas, John
Relator code edt
9 (RLIN) 1625499
245 10 - TITLE STATEMENT
Title Advances in Multiple Sclerosis Research-Series I
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Basel, Switzerland
Name of publisher, distributor, etc MDPI - Multidisciplinary Digital Publishing Institute
Date of publication, distribution, etc 2021
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (334 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
-- https://creativecommons.org/licenses/by/4.0/
-- cc
-- https://creativecommons.org/licenses/by/4.0/
546 ## - LANGUAGE NOTE
Language note English
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine
Source of heading or term bicssc
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term multiple sclerosis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term inflammation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term oxidative
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term biomarker
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term sample size
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term autoimmune encephalitis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term plasma exchange
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term autoimmunity
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immunotherapeutics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term clinical outcomes
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term major depression
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term bupropion
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term S-adenosylmethionine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term vitamin D3
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term yoga
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term craniopharyngioma
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term fractionated stereotactic radiation treatments
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term sphenoid sinusitis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cranial nerve-VI palsy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term autoimmune diseases
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immune thrombocytopenic purpura
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term alemtuzumab
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term antibodies against GluR3 peptide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cognitive impairment
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term diagnosis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term neuropsychological assessment
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term short intracortical inhibition
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term intracortical facilitation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term fampridine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term walking disability
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term TSPAN32
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tetraspanins
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cellular immunity
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term memory T cells
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tDCS
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term neuroimaging
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term positron emission tomography
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cerebral blood flow
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term probiotics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Streptococcus thermophilus
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term ST285
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term MBP83-99 peptide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term mannan
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immune modulation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term agonist peptide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term gut microbiome
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term gut-brain axis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term metagenomics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term disease-modifying treatments
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term MS
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term vaccine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immunomodulation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term carriers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term B cell receptor
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term delivery methods
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immunotherapy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term monoclonal antibodies
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term T cell receptor
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tolerance
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term diagnostic markers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immunoglobulins
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term kappa
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term free light chains
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term antigen-specific immunotherapies
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tolerogenic vaccines
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tolerance induction
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term central nervous system
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term myelin peptides
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term myelin basic protei
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term proteolipid protein
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term myelin oligodendrocyte glycoprotein
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanotechnology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term drug delivery nanosystems
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term lipids
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polymers
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term vaccines
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term antigen-specific immunotherapy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term experimental autoimmune encephalomyelitis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term neurodegeneration
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term chloroquine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term EAE
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term dendritic cells
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term microglia
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term astrocytes
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term oligodendrocytes
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term conformational analysis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term peptides
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term altered peptide ligands
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term NMR spectroscopy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term NOE-constraints
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term molecular dynamic
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term trimolecular complex
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Multiple Sclerosis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term early-onset
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term adult-onset
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Human Leucocyte Antigens
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immunogenetics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term clinical phenotype
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term clinical outcome
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term therapeutics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term antibody detection
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term ELISA
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term multivalency
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term N-glucosylated peptide epitopes
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term peptide
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term conjugation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term MOG35-55
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Graphite/SiO2 electrode
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term voltammetry
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term HPLC
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term MS drugs
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Apostolopoulos, Vasso
Relator code edt
9 (RLIN) 1625500
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matsoukas, John
Relator code oth
9 (RLIN) 1625499
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Apostolopoulos, Vasso
Relator code oth
9 (RLIN) 1625500
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/3604">https://mdpi.com/books/pdfview/book/3604</a>
-- 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/68583">https://directory.doabooks.org/handle/20.500.12854/68583</a>
-- 0
Public note DOAB: description of the publication
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        E-Books Open Access OPJGU Sonepat- Campus OPJGU Sonepat- Campus 14/07/2022   14/07/2022 14/07/2022 Electronic-Books

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library